Genetic Variants in Cytosolic 5′-Nucleotidase II Are Associated with Its Expression and Cytarabine Sensitivity in HapMap Cell Lines and in Patients with Acute Myeloid Leukemia

Cytosolic 5′-nucleotidase II (NT5C2) is involved in the development of 1-β-d-arabinofuranosylcytosine (ara-C) resistance and has been associated with clinical outcome in patients receiving ara-C-based chemotherapy. NT5C2 inactivates ara-C by dephosphorylating ara-C monophosphate to ara-C. In this st...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Mitra, Amit K., Crews, Kristine R., Pounds, Stanley, Cao, Xueyuan, Feldberg, Tanya, Ghodke, Yogita, Gandhi, Varsha, Plunkett, William, Dolan, M. Eileen, Hartford, Christine, Raimondi, Susana, Campana, Dario, Downing, James, Rubnitz, Jeffrey E., Ribeiro, Raul C., Lamba, Jatinder K.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: The American Society for Pharmacology and Experimental Therapeutics 2011
Gaiak:
Metabolism, Transport, and Pharmacogenomics
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3186292/
https://ncbi.nlm.nih.gov/pubmed/21712425
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1124/jpet.111.182873
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak